星湖品牌怎么样 申请店铺

我要投票 星湖在味精行业中的票数:284 更新时间:2025-06-19
星湖是哪个国家的品牌?「星湖」是 广东肇庆星湖生物科技股份有限公司 旗下著名品牌。该品牌发源于广东,由创始人陈武在1992-04-18期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力星湖品牌出海!将品牌入驻外推网,定制星湖品牌推广信息,可以显著提高星湖产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

星湖怎么样

广东肇庆星湖生物科技股份有限公司是以生物发酵和生物化工为核心技术的制造型企业。公司的前身是1964年创建的农业微生物药厂,1981年转产味精,1992年在原国有企业肇庆味精厂的基础上转制成立股份公司,是广东省首批八家股份制改革试点企业之一。1994年8月公司股份在上海证交所上市,证券简称“星湖科技”,股票代码:600866。2009年4月,广东省广新控股集团受让肇庆市国资委持有的星湖科技国有控股权,成为星湖科技的第一大股东,现持有公司股份的17.52%。现公司总股本5.5亿股,为全流通股,员工3000多人。截至2011年12月止,公司总资产34.22亿元,净资产18.02亿元。

公司拥有国家级企业技术中心和博士后科研工作站,是广东省高新技术企业、广东省技术创新优势企业、国家火炬计划重点高新技术企业、国家火炬计划优秀高新技术企业。荣获中国食品工业协会颁发的2005-2006年度“全国食品工业优秀龙头食品企业”称号和中国食品工业质量效益奖。2008年10月,广东省食品行业和医药行业协会授予公司为改革开放三十年广东省医药行业创新企业、广东省医药和食品行业突出贡献企业、广东省食品行业节能减排贡献企业、广东省生物制药产业10强企业等称号。中国发酵工业协会于2008年10月推荐公司为“全国发酵行业循环经济试点企业”。广东省企业联合会和企业家协会授予公司为2009年、2010年“广东省最具核心竞争力企业”、“2010—2011年广东省企业500强”、“2010—2011年广东省制造业100强企业”,2011年广东省自主创新标杆企业。2009年,公司“星湖牌”商标被国家工商行政管理总局认定为中国驰名商标。“星湖牌”、“粤宝牌”荣获2010年度广东省优秀自主品牌,2011年被评定为广东省著名商标。

公司主导产品有:星湖牌食品系列。其中呈味核苷酸二钠(I加G)、肌苷酸二钠(IMP)、鸟苷酸二钠(GMP)是填补国内空白,拥有自主知识产权和民族品牌的国家重点新产品,并受到国家两次对外反倾销措施保护;果葡糖是新开发的产品。星湖牌饲料添加剂—L-苏氨酸、赖氨酸。粤宝牌医药系列——肌苷、利巴韦林、脯氨酸、鸟苷、阿德福韦酯、腺苷、缬氨酸、核糖、腺嘌呤、精氨酸等。其中肌苷和利巴韦林的生产规模居全球前列。

公司通过了ISO9001:2008质量管理体系认证。利巴韦林产品通过了美国FDA认证、澳大利亚TGA检查,核苷酸产品(I加G、IMP、GMP)通过了FSSC22000食品安全管理体系认证和KOSHER认证、HALAL认证;脯氨酸产品通过了COS认证、KOSHER认证、HALAL认证;肌苷产品通过了KOSHER认证;粤宝牌医药产品通过了国家GMP认证;苏氨酸产品通过了欧盟FAMI-QS认证、HACCP认证;果葡糖产品通过了FSSC22000食品安全管理体系认证。完善的质量管理体系保证了产品质量达到国际先进水平。

公司坚持以科学发展观为指导,以加快转型升级为主线,继续解放思想,坚持改革创新,提高自主创新能力,提高企业管理水平,加强企业全面风险管理,大力实施产业发展高端化和企业经营国际化战略,走能源、资源、原材料依赖性少,科技含量高、附加值高、市场容量大、环保、节能、清洁生产的产业发展道路,打造核心产业和核心业务,建设华南生物工程产业生产研发基地、华南有色金属高端产业生产研发基地,以企业价值最大化为目标,积极为股东创造效益,不断优化和推进公司的可持续发展,努力把公司打造成为中国名牌优质企业。

Guangdong Zhaoqing Xinghu Biotechnology Co., Ltd. is a manufacturing enterprise with the core technology of biological fermentation and biochemical industry. The predecessor of the company is the agricultural microbial pharmaceutical factory established in 1964, which was converted to monosodium glutamate production in 1981. In 1992, the company was transformed into a joint-stock company based on the original state-owned enterprise Zhaoqing monosodium glutamate factory. It is one of the first eight joint-stock reform pilot enterprises in Guangdong Province. In August 1994, the company's shares were listed on the Shanghai Stock Exchange, and the securities are referred to as "Star Lake Technology", stock code: 600866. In April 2009, Guangdong Guangxin holding group transferred the state-owned holding right of Xinghu technology held by Zhaoqing SASAC, becoming the largest shareholder of Xinghu technology, and now holds 17.52% of the company's shares. At present, the company has a total share capital of 550 million shares, which is fully tradable, with more than 3000 employees. As of December 2011, the company's total assets are 3.422 billion yuan, and its net assets are 1.802 billion yuan. The company has national enterprise technology center and postdoctoral research workstation, and is a high-tech enterprise in Guangdong Province, a technological innovation advantage enterprise in Guangdong Province, a key high-tech enterprise in the national torch plan, and an excellent high-tech enterprise in the national torch plan. It was awarded the title of "national excellent leading food enterprise in food industry" and the quality and Efficiency Award of China food industry in 2005-2006 by China Food Industry Association. In October 2008, Guangdong food industry and Pharmaceutical Industry Association awarded the company the titles of innovation enterprise of Guangdong pharmaceutical industry, outstanding contribution enterprise of Guangdong pharmaceutical and food industry, energy conservation and emission reduction contribution enterprise of Guangdong food industry, top 10 enterprises of Guangdong biopharmaceutical industry, etc. for the 30 years of reform and opening up. In October 2008, China Fermentation Industry Association recommended the company as "national pilot enterprise of circular economy in fermentation industry". Guangdong Enterprise Federation and Entrepreneur Association awarded the company as "the most core competitive enterprise in Guangdong Province", "top 500 enterprises in Guangdong Province from 2010 to 2011", "top 100 manufacturing enterprises in Guangdong Province from 2010 to 2011" in 2009 and 2010, and "independent innovation benchmark enterprise in Guangdong Province" in 2011. In 2009, the company's "Xinghu brand" trademark was recognized as a well-known trademark by the State Administration for Industry and commerce. "Xinghu brand" and "Yuebao brand" were awarded the excellent independent brand of Guangdong Province in 2010, and were awarded the famous trademark of Guangdong Province in 2011. The company's leading products are: Xinghu brand food series. Among them, disodium nucleotides (I plus g), disodium Inosinate (IMP) and disodium guanosinate (GMP) are the national key new products that fill the domestic blank, have independent intellectual property rights and national brands, and are protected by the national anti-dumping measures twice; fructose is the newly developed product. Xinghu brand feed additives - l-threonine, lysine. Yuebao pharmaceutical series - inosine, ribavirin, proline, guanosine, adefovir ester, adenosine, valine, ribose, adenine, arginine, etc. The production scale of inosine and ribavirin ranks the top in the world. The company has passed ISO9001:2008 quality management system certification. Ribavirin products have passed FDA certification and TGA inspection in Australia, nucleotide products (I plus g, imp, GMP) have passed fssc22000 food safety management system certification, kosher certification and Halal certification, proline products have passed cos certification, kosher certification and Halal certification, inosine products have passed kosher certification, Yuebao pharmaceutical products have passed national GMP certification, threonine production has passed kosher certification The product has passed the EU fami-qs certification and HACCP certification; the fructose product has passed the fssc22000 food safety management system certification. The perfect quality management system ensures the product quality to reach the international advanced level. The company adheres to the guidance of the scientific outlook on development, the main line of accelerating transformation and upgrading, continues to emancipate the mind, adhere to reform and innovation, improve the ability of independent innovation, improve the level of enterprise management, strengthen the overall risk management of the enterprise, vigorously implement the strategy of high-end industrial development and international enterprise operation, with less dependence on energy, resources and raw materials, high scientific and technological content, high added value The industrial development path of large market capacity, environmental protection, energy conservation and clean production, the construction of core industries and core businesses, the construction of South China bioengineering industry production and R & D base, South China high-end non-ferrous metal industry production and R & D base, with the goal of maximizing enterprise value, actively create benefits for shareholders, constantly optimize and promote the sustainable development of the company, and strive to build the company into a It is a famous and high-quality enterprise in China.

本文链接: https://brand.waitui.com/8144824d5.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

公募基金半年收益榜“剧透”,创新药配置价值凸显

Wind资讯数据显示,截至6月18日,医药类基金以平均超19%的净值增长率脱颖而出,在年内基金收益排名前100名中占据近“半壁江山”,引发市场对医药板块尤其是创新药领域配置价值的广泛关注。创新药作为医药板块中具备较好成长性和产业逻辑的细分领域,或持续受益于全球医药产业链重构与中国药企研发实力提升的双重红利。多位基金经理在分享创新药的投资逻辑时普遍认为,相关政策支持给予医药企业较大发展空间,创新药板块存在价值洼地,多家企业估值已具备吸引力。

58分钟前

单只基金单次分红金额达84亿元,刷新纪录

6月18日,作为目前规模最大宽基指数ETF,华泰柏瑞沪深300ETF分红总金额落定,基金的单次分红金额达到84亿元,刷新境内ETF市场单次分红纪录。业内人士分析,目前,ETF产品正在不断增强分红能力,与债券基金一道,成为当前市场分红的两大核心力量。在资金结构持续演化、“长钱”加速入市的背景下,基金的分红机制日益成为投资者关注的重要指标。(证券时报)

58分钟前

加拿大矿业公司Franco-Nevada暂停巴拿马矿业仲裁

当地时间6月18日,加拿大矿业公司Franco-Nevada表示,已同意暂停其针对巴拿马的仲裁程序。2024年6月27日,该公司曾根据《加拿大-巴拿马自由贸易协定》向国际投资争端解决中心提交了仲裁申请。(界面)

58分钟前

中信建投:IP新消费前路坦荡,AI应用星星之火

36氪获悉,中信建投研报称,1.IP新消费前路坦荡:小情绪,大空间。内容向的新消费持续景气,中信建投认为满足三个条件就是广义的新消费,满足即刻情绪价值、高频多次消费、赛道增速快。因此从线下的潮玩和演出,到线上的游戏与音乐,都是有潜力的新消费赛道,看好长期增长空间广阔。2.AI应用星星之火,AI Agent与多模态进展领先。随着以DeepSeek为首的推理模型加速迭代,今年迎来Agent和AI视频的落地元年。

58分钟前

日本6月13日当周外资净买进日本股票4743亿日元

6月19日消息,日本至6月13日当周外资买进日股4734亿日元,前值由1802亿日元修正为1798亿日元。(界面)

58分钟前

本页详细列出关于星湖的品牌信息,含品牌所属公司介绍,星湖所处行业的品牌地位及优势。
咨询